Regional strategy to improve access to medicines and vaccines in the Eastern Mediterranean, 2020–2030, including lessons from the COVID-19 pandemic

WHO Global Benchmarking Tool (GBT) for evaluation of national regulatory system of medical products: revision VI

Manual for benchmarking of the national regulatory system of medical products and formulation of institutional development plans

Implementation guide for health systems recovery in emergencies: transforming challenges into opportunities

Delivering quality-assured medical products for all 2019–2023: WHO’s five-year plan to help build effective and efficient regulatory systems

Implementing quality management systems in national regulatory authorities: examples and practices

Evaluating and publicly designating regulatory authorities as WHO listed authorities: policy document

Regulation of vaccines: building on existing drug regulatory authorities

Guidelines on regulatory preparedness for provision of marketing authorization of human pandemic influenza vaccines in non-vaccine-producing countries: annex 7, WHO Technical Report Series No. 1004

Managing conflicts of interest: a how-to guide for public pharmaceutical-sector committees in low- and middle-income countries[LD1] 

Shaping the global innovation and access landscape for better paediatric medicines: Global Accelerator for Paediatric Formulations 2022–2024 strategy

Promoting access to medical technologies and innovation: intersections between public health, intellectual property and trade

Guidance for post-market surveillance and market surveillance of medical devices, including in vitro diagnostics

Policy paper on traceability of medical products

The WHO Member State Mechanism on Substandard and Falsified Medical Products: how WHO Member States work together to safeguard access to safe and effective medicines, vaccines and other medical products

A study on the public health and socioeconomic impact of substandard and falsified medical products

WHO model list of essential medicines: 22nd list (2021)

WHO model list of essential medicines for children: 8th list (2021)

The interagency emergency health kit 2017: medicines and medical devices for 10 000 people for approximately three months

The pursuit of responsible use of medicines: sharing and learning from country experiences

The role of intellectual property in local production in developing countries: opportunities and challenges

Regulation of medical devices: a step-by-step guide 

Blood and other products of human origin

Action framework to advance universal access to safe, effective and quality-assured blood products 2020–2023[LD3] 

Global status report on blood safety and availability 2021

Global status report on blood safety and availability 2016

Guidance on centralization of blood donation testing and processing

Guidance on increasing supplies of plasma-derived medicinal products in low- and middle-income countries through fractionation of domestic plasma

A guide to establishing a national haemovigilance system

Maintaining a safe and adequate blood supply and collecting convalescent blood plasma in the context of the COVID-19 pandemic: interim guidance

Regional status report on blood safety and availability 2016

Strategic framework for blood safety and availability 2016–2025

The urgent need to implement patient blood management: policy brief